Latest Headlines
-
C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity Blood Testing For Alzheimer’s Disease And Brain Research Market
4/26/2024
C₂N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier provider of clinical research to the biopharma industry throughout Japan.
-
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
4/25/2024
StatLab Medical Products (“StatLab”), a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced the acquisition of Scientific Device Laboratory (“SDL”), a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
-
Microbix Collaborator Introduces New Lab Accreditation Program
4/25/2024
Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“QAPs™”) for accreditation of clinical labs for conducting molecular (“MDx”) tests for antimicrobial-resistant (“AMR”) strains of M. genitalium (“Mgen”), a common sexually-transmitted infection (“STI”).
-
Revvity Unveils A New Era Of Automated Tuberculosis Testing
4/24/2024
Revvity, Inc.today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient workflows in the lab.
-
ARUP Partners With ELLKAY To Bring Connectivity Solutions To Health System Outreach Operations
4/24/2024
ARUP Laboratories and healthcare connectivity company ELLKAY have forged a new partnership aimed at helping health systems establish or expand successful laboratory outreach operations.
-
Clarapath Forms Strategic Collaboration With Mayo Clinic To Advance Pathology Tissue Processing
4/23/2024
Clarapath, a medical robotics company transforming the way pathology laboratories process tissue, announced it has entered into a strategic collaboration with Mayo Clinic to propel a new era of laboratory automation.
-
Sapio Sciences Launches New Multimodal Registration Capabilities For Its Lab Informatics Platform
4/23/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the launch of its new multimodal registration capabilities.
-
Copia Scientific Enters Agreement With Leading Pharmaceutical Company
4/23/2024
Copia Scientific, a provider of laboratory equipment and service solutions, is pleased to announce that it has entered into a strategic agreement with a top 10 global Fortune 50 pharmaceutical company.
-
Multiply Labs And GenScript Biotech Corporation Collaborate To Automate The Cell Isolation And Enrichment Phase Of Cell Therapy Manufacturing
4/23/2024
GenScript Biotech Corporation (GenScript), one of the world's leading providers of life-science research tools and services, and Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, today announced a strategic partnership around the automation of the cell isolation phase of cell therapy manufacturing, reducing the complexity of this laborious process.
-
Labconnect Acquires Scientific Consultancy A4P
4/22/2024
LabConnect has announced the acquisition of A4P Consulting Ltd (A4P), a scientific consultancy company, specializing in bioanalytical and biosample project management, biomarker strategy and logistics solutions in support of pre-clinical and clinical trials.